We are live on ! Find out more
CRVO icon

CervoMed
CRVO

12 hedge funds and large institutions have $1.68M invested in CervoMed in 2023 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 6 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

185% more capital invested

Capital invested by funds: $590K → $1.68M (+$1.09M)

100% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 2

9% more funds holding

Funds holding: 11 → 12 (+1)

1.3% more ownership

Funds ownership: 5.78% → 7.08% (+1.3%)

83% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 6

Holders
12
Holders Change
+1
Holders Change %
+9.09%
% of All Funds
0.19%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
1
Reduced
6
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$1M
2
RSCM
Rock Springs Capital Management
Maryland
+$403K
3
Renaissance Technologies
Renaissance Technologies
New York
+$11.9K
4
HI
Hoey Investments
Pennsylvania
+$5.44K
5
Citigroup
Citigroup
New York
+$5

Top Sellers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
-$122K
2
BCM
Bridgeway Capital Management
Texas
-$55K
3
TRCT
Tower Research Capital (TRC)
New York
-$6.61K
4
Geode Capital Management
Geode Capital Management
Massachusetts
-$1.63K
5
UBS Group
UBS Group
Switzerland
-$200

CRVO Hedge Fund Activity: Q3 2023 in Review

12 of the 6,310 institutional investors tracked by Wall St. Rank reported a position in CervoMed (CRVO) for Q3 2023, worth a combined $1.68M — up 185% from $590K a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new CRVO positions and 2 closed out — a net gain of 2 holders — while 1 added to existing stakes and 6 trimmed.

The largest buyer was Adage Capital Partners, opening a new position worth an estimated $1M. The largest seller was Vanguard Group, cutting an estimated $122K.

  • 12 institutional investors held CervoMed (CRVO) as of Q3 2023, up from 11 in Q2 2023.
  • Funds reported $1.68M of CervoMed stock for Q3 2023, up 185% quarter-over-quarter.
  • 4 funds opened new CervoMed positions in Q3 2023 and 2 closed out, a net change of +2 holders.
  • The largest CervoMed buyer in Q3 2023 was Adage Capital Partners, an estimated $1M added.
  • The largest CervoMed seller in Q3 2023 was Vanguard Group, an estimated $122K sold.

Based on aggregated 13F filings for Q3 2023.